title: Successful combination treatment with bevacizumab, thalidomide and autologous PBSC for severe POEMS syndrome.
authors.forename: C
authors.initials: C
authors.lastname: Ohwada
authors.forename: C
authors.initials: C
authors.lastname: Nakaseko
authors.forename: S
authors.initials: S
authors.lastname: Sakai
authors.forename: Y
authors.initials: Y
authors.lastname: Takeda
authors.forename: D
authors.initials: D
authors.lastname: Abe
authors.forename: M
authors.initials: M
authors.lastname: Takeuchi
authors.forename: E
authors.initials: E
authors.lastname: Sakaida
authors.forename: S
authors.initials: S
authors.lastname: Masuda
authors.forename: N
authors.initials: N
authors.lastname: Shimizu
authors.forename: R
authors.initials: R
authors.lastname: Cho
authors.forename: M
authors.initials: M
authors.lastname: Nishimura
authors.forename: K
authors.initials: K
authors.lastname: Kanai
authors.forename: S
authors.initials: S
authors.lastname: Misawa
authors.forename: S
authors.initials: S
authors.lastname: Kuwabara
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000068258:Bevacizumab; D003131:Combined Modality Therapy / Q000379:methods; D006801:Humans; D008297:Male; D008875:Middle Aged; D016878:POEMS Syndrome / Q000628:therapy*; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods*; D013792:Thalidomide / Q000008:administration & dosage*; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D013792:Thalidomide